Fundz

Orano Med Inaugurates ATLab Valenciennes to Produce Lead-212-Based Targeted Alpha Therapies in Europe.

Oct 03, 2026

Contract Type

partnership

PlanoBiotechnologyHealth Care

Description

Orano Med has inaugurated its ATLab Valenciennes, marking the first industrial facility in Europe dedicated to lead-212-based targeted alpha therapies. This facility represents a €29 million investment and aims to produce up to 10,000 doses annually to meet the growing needs of patients.

Company Information

Company

Orano Med

Location

Plano, Texas, United States

About

Orano Med is a company that combines biotechnologies and nuclear technology to develop new therapies offering new therapeutic solutions to patients with resistant forms of cancer. Orano Med is continuing to develop targeted alpha therapy treatments, a unique technology which combines the capacity of biological molecules to target cancer cells with the properties of lead-212 (212Pb), which is able to destroy them while limiting the impact on surrounding healthy cells.

Related People

Arnaud
Senior decision-maker at this company
••••••••@••••••••

See Arnaud's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Orano Med's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Orano Med signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.